MMJ Recs
DECEMBER 17, 2023
Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. The Texas Compassionate Use Program (TCUP) represents the Lone Star State’s cautious foray into the realm of medical marijuana.
Cannabis Law Report
SEPTEMBER 6, 2021
The global medical cannabis market exhibited strong growth during 2015-2020. Clinical trials, research and development (R&D) activities and commercialization of cannabis-based indications are further expected to catalyze the growth of the market. during 2021-2026. Companies Mentioned. Canopy Growth Corporation. Chronic Pain.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Canna Care Docs
DECEMBER 16, 2020
The evidence of its effectiveness is clear, as clinical trials have shown a significant reduction in pain for patients suffering with neuropathic pain from multiple sclerosis, pain from rheumatoid arthritis, cancer pain, HIV or complex regional pain syndrome, headaches and menstrual pain, among other potential uses. Chronic pain.
Cannabis Law Report
DECEMBER 28, 2021
The users of CBD products claim to have seen improvement in different medical conditions, including depression, chronic pain, insomnia, epilepsy, anxiety, etc., But things have changed after FDA eased out regulations in 2015 to carry out CBD trials. after its consumption. So, there are huge developments after that.
Greencamp
AUGUST 16, 2018
The CBD cannabinoid is proven to be an exceptional seizure-controlling agent for epilepsy patients, and also shows great promise for treating Parkinson’s , Alzheimer’s and Multiple Sclerosis. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies). Exploring the available research on ALS and cannabinoids.
Cannabis Law Report
FEBRUARY 15, 2019
The Institute of Mental Health (IMH) did a review of 500 articles between 1964 and 2015 on the effects of cannabis. There is even published research, derived from clinical trials, on the potential uses of cannabinoids to manage seizures and epilepsy, cited the ministries. It causes serious brain damage.
Cannabis Law Report
JANUARY 26, 2022
The Innovation Passport does not reduce the burden of demonstrating that a treatment may be safe and effective, but does provide research organizers with expert advice, patient input, and collaboration throughout the clinical trial design and development process through a product-specific Target Development Profile.
Expert insights. Personalized for you.
52 
Let's personalize your content